nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—GABRA3—Graves' disease	0.548	1	CbGaD
Sevoflurane—CYP2A6—Methimazole—Graves' disease	0.134	0.398	CbGbCtD
Sevoflurane—CYP2E1—Methimazole—Graves' disease	0.0883	0.263	CbGbCtD
Sevoflurane—CYP2B6—Methimazole—Graves' disease	0.0871	0.259	CbGbCtD
Sevoflurane—CYP3A4—Methimazole—Graves' disease	0.0267	0.0796	CbGbCtD
Sevoflurane—GLRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00364	0.0469	CbGpPWpGaD
Sevoflurane—GABRQ—GABA A receptor activation—GABRA3—Graves' disease	0.00304	0.0392	CbGpPWpGaD
Sevoflurane—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.0025	0.0323	CbGpPWpGaD
Sevoflurane—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00247	0.0318	CbGpPWpGaD
Sevoflurane—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00233	0.0301	CbGpPWpGaD
Sevoflurane—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.0023	0.0297	CbGpPWpGaD
Sevoflurane—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00211	0.0271	CbGpPWpGaD
Sevoflurane—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00205	0.0264	CbGpPWpGaD
Sevoflurane—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00198	0.0255	CbGpPWpGaD
Sevoflurane—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00196	0.0253	CbGpPWpGaD
Sevoflurane—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00193	0.0248	CbGpPWpGaD
Sevoflurane—GABRQ—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00186	0.024	CbGpPWpGaD
Sevoflurane—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00168	0.0217	CbGpPWpGaD
Sevoflurane—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00153	0.0198	CbGpPWpGaD
Sevoflurane—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00151	0.0195	CbGpPWpGaD
Sevoflurane—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00143	0.0184	CbGpPWpGaD
Sevoflurane—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00141	0.0182	CbGpPWpGaD
Sevoflurane—Hepatic failure—Propylthiouracil—Graves' disease	0.00139	0.0688	CcSEcCtD
Sevoflurane—Renal failure acute—Propylthiouracil—Graves' disease	0.00135	0.067	CcSEcCtD
Sevoflurane—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00129	0.0166	CbGpPWpGaD
Sevoflurane—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00125	0.0162	CbGpPWpGaD
Sevoflurane—GRIA1—eye—Graves' disease	0.00124	0.0669	CbGeAlD
Sevoflurane—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00121	0.0156	CbGpPWpGaD
Sevoflurane—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0012	0.0155	CbGpPWpGaD
Sevoflurane—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00118	0.0152	CbGpPWpGaD
Sevoflurane—KCNK2—adipose tissue—Graves' disease	0.00117	0.0636	CbGeAlD
Sevoflurane—Jaundice—Methimazole—Graves' disease	0.0011	0.0546	CcSEcCtD
Sevoflurane—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00103	0.0133	CbGpPWpGaD
Sevoflurane—KCNK2—thyroid gland—Graves' disease	0.00102	0.055	CbGeAlD
Sevoflurane—Hepatitis—Methimazole—Graves' disease	0.00101	0.0503	CcSEcCtD
Sevoflurane—GABRQ—GABA receptor activation—GABRA3—Graves' disease	0.000988	0.0127	CbGpPWpGaD
Sevoflurane—Jaundice—Propylthiouracil—Graves' disease	0.000936	0.0465	CcSEcCtD
Sevoflurane—ATP2C1—Ion channel transport—GABRA3—Graves' disease	0.000928	0.012	CbGpPWpGaD
Sevoflurane—GRIA1—adipose tissue—Graves' disease	0.000915	0.0495	CbGeAlD
Sevoflurane—GABRG3—pituitary gland—Graves' disease	0.000889	0.0481	CbGeAlD
Sevoflurane—Haemoglobin—Propylthiouracil—Graves' disease	0.000867	0.043	CcSEcCtD
Sevoflurane—Haemorrhage—Propylthiouracil—Graves' disease	0.000862	0.0428	CcSEcCtD
Sevoflurane—Hepatitis—Propylthiouracil—Graves' disease	0.000862	0.0428	CcSEcCtD
Sevoflurane—ATP5D—connective tissue—Graves' disease	0.000826	0.0447	CbGeAlD
Sevoflurane—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.000813	0.0105	CbGpPWpGaD
Sevoflurane—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.000801	0.0103	CbGpPWpGaD
Sevoflurane—GLRA1—Ion channel transport—GABRA3—Graves' disease	0.000789	0.0102	CbGpPWpGaD
Sevoflurane—KCNA1—thyroid gland—Graves' disease	0.000773	0.0418	CbGeAlD
Sevoflurane—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.000758	0.00977	CbGpPWpGaD
Sevoflurane—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.000749	0.00964	CbGpPWpGaD
Sevoflurane—Dysgeusia—Propylthiouracil—Graves' disease	0.000735	0.0365	CcSEcCtD
Sevoflurane—Oedema—Methimazole—Graves' disease	0.00072	0.0358	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methimazole—Graves' disease	0.000705	0.035	CcSEcCtD
Sevoflurane—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.000702	0.00905	CbGpPWpGaD
Sevoflurane—GABRB1—pituitary gland—Graves' disease	0.000687	0.0372	CbGeAlD
Sevoflurane—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.000685	0.00882	CbGpPWpGaD
Sevoflurane—ND1—thyroid gland—Graves' disease	0.000681	0.0368	CbGeAlD
Sevoflurane—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.000665	0.00857	CbGpPWpGaD
Sevoflurane—KCNK18—Neuronal System—GABRA3—Graves' disease	0.000646	0.00833	CbGpPWpGaD
Sevoflurane—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.000642	0.00827	CbGpPWpGaD
Sevoflurane—Somnolence—Methimazole—Graves' disease	0.000641	0.0318	CcSEcCtD
Sevoflurane—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000638	0.00822	CbGpPWpGaD
Sevoflurane—ATP5D—pituitary gland—Graves' disease	0.000636	0.0344	CbGeAlD
Sevoflurane—ATP5D—adipose tissue—Graves' disease	0.000634	0.0343	CbGeAlD
Sevoflurane—ATP2C1—pituitary gland—Graves' disease	0.000628	0.034	CbGeAlD
Sevoflurane—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000626	0.00807	CbGpPWpGaD
Sevoflurane—ATP2C1—adipose tissue—Graves' disease	0.000626	0.0339	CbGeAlD
Sevoflurane—GABRA4—pituitary gland—Graves' disease	0.00062	0.0336	CbGeAlD
Sevoflurane—GABRP—pituitary gland—Graves' disease	0.000616	0.0333	CbGeAlD
Sevoflurane—Oedema—Propylthiouracil—Graves' disease	0.000613	0.0304	CcSEcCtD
Sevoflurane—Thrombocytopenia—Propylthiouracil—Graves' disease	0.0006	0.0298	CcSEcCtD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000599	0.00772	CbGpPWpGaD
Sevoflurane—GABRQ—Orphan transporters—GABRA3—Graves' disease	0.000576	0.00742	CbGpPWpGaD
Sevoflurane—Urticaria—Methimazole—Graves' disease	0.000572	0.0284	CcSEcCtD
Sevoflurane—Body temperature increased—Methimazole—Graves' disease	0.00057	0.0283	CcSEcCtD
Sevoflurane—GABRA3—thyroid gland—Graves' disease	0.000549	0.0297	CbGeAlD
Sevoflurane—ATP5D—thyroid gland—Graves' disease	0.000549	0.0297	CbGeAlD
Sevoflurane—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000547	0.00705	CbGpPWpGaD
Sevoflurane—Somnolence—Propylthiouracil—Graves' disease	0.000545	0.027	CcSEcCtD
Sevoflurane—ATP2C1—thyroid gland—Graves' disease	0.000542	0.0293	CbGeAlD
Sevoflurane—GABRB3—eye—Graves' disease	0.000537	0.029	CbGeAlD
Sevoflurane—CYP2A6—adipose tissue—Graves' disease	0.000534	0.0289	CbGeAlD
Sevoflurane—KCNK10—Neuronal System—GABRA3—Graves' disease	0.000527	0.00679	CbGpPWpGaD
Sevoflurane—GABRG2—pituitary gland—Graves' disease	0.000519	0.0281	CbGeAlD
Sevoflurane—GABRB3—connective tissue—Graves' disease	0.000517	0.028	CbGeAlD
Sevoflurane—KCNA1—Neuronal System—GABRA3—Graves' disease	0.000511	0.00658	CbGpPWpGaD
Sevoflurane—Pruritus—Methimazole—Graves' disease	0.00051	0.0253	CcSEcCtD
Sevoflurane—KCNK2—Neuronal System—GABRA3—Graves' disease	0.000504	0.00649	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—GABRA3—Graves' disease	0.00049	0.00631	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—GABRA3—Graves' disease	0.00049	0.00631	CbGpPWpGaD
Sevoflurane—Urticaria—Propylthiouracil—Graves' disease	0.000487	0.0242	CcSEcCtD
Sevoflurane—Body temperature increased—Propylthiouracil—Graves' disease	0.000484	0.024	CcSEcCtD
Sevoflurane—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000474	0.00611	CbGpPWpGaD
Sevoflurane—GABRA2—adipose tissue—Graves' disease	0.000472	0.0255	CbGeAlD
Sevoflurane—GABRE—pituitary gland—Graves' disease	0.00047	0.0254	CbGeAlD
Sevoflurane—GABRE—adipose tissue—Graves' disease	0.000468	0.0253	CbGeAlD
Sevoflurane—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000467	0.00602	CbGpPWpGaD
Sevoflurane—Vomiting—Methimazole—Graves' disease	0.000458	0.0227	CcSEcCtD
Sevoflurane—Rash—Methimazole—Graves' disease	0.000454	0.0225	CcSEcCtD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000454	0.00585	CbGpPWpGaD
Sevoflurane—Dermatitis—Methimazole—Graves' disease	0.000454	0.0225	CcSEcCtD
Sevoflurane—Headache—Methimazole—Graves' disease	0.000451	0.0224	CcSEcCtD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00045	0.0058	CbGpPWpGaD
Sevoflurane—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000442	0.0057	CbGpPWpGaD
Sevoflurane—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000437	0.00562	CbGpPWpGaD
Sevoflurane—Pruritus—Propylthiouracil—Graves' disease	0.000433	0.0215	CcSEcCtD
Sevoflurane—Nausea—Methimazole—Graves' disease	0.000428	0.0212	CcSEcCtD
Sevoflurane—GABRE—thyroid gland—Graves' disease	0.000405	0.0219	CbGeAlD
Sevoflurane—GABRQ—Ion channel transport—GABRA3—Graves' disease	0.000404	0.00521	CbGpPWpGaD
Sevoflurane—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000399	0.00514	CbGpPWpGaD
Sevoflurane—GABRB3—pituitary gland—Graves' disease	0.000398	0.0216	CbGeAlD
Sevoflurane—Vomiting—Propylthiouracil—Graves' disease	0.00039	0.0193	CcSEcCtD
Sevoflurane—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000388	0.005	CbGpPWpGaD
Sevoflurane—Rash—Propylthiouracil—Graves' disease	0.000386	0.0192	CcSEcCtD
Sevoflurane—Dermatitis—Propylthiouracil—Graves' disease	0.000386	0.0192	CcSEcCtD
Sevoflurane—Headache—Propylthiouracil—Graves' disease	0.000384	0.019	CcSEcCtD
Sevoflurane—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000374	0.00482	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000374	0.00482	CbGpPWpGaD
Sevoflurane—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000372	0.00479	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000368	0.00475	CbGpPWpGaD
Sevoflurane—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000365	0.0047	CbGpPWpGaD
Sevoflurane—Nausea—Propylthiouracil—Graves' disease	0.000364	0.0181	CcSEcCtD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000349	0.00449	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—GABRA3—Graves' disease	0.000345	0.00445	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000344	0.00443	CbGpPWpGaD
Sevoflurane—GABRB3—thyroid gland—Graves' disease	0.000343	0.0186	CbGeAlD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000341	0.0044	CbGpPWpGaD
Sevoflurane—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000333	0.00429	CbGpPWpGaD
Sevoflurane—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000328	0.00422	CbGpPWpGaD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000323	0.00416	CbGpPWpGaD
Sevoflurane—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000319	0.00411	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000315	0.00406	CbGpPWpGaD
Sevoflurane—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.00031	0.004	CbGpPWpGaD
Sevoflurane—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000306	0.00395	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000306	0.00394	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000295	0.0038	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000293	0.00378	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000288	0.00371	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000281	0.00362	CbGpPWpGaD
Sevoflurane—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.00028	0.00361	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000277	0.00357	CbGpPWpGaD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000275	0.00354	CbGpPWpGaD
Sevoflurane—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000272	0.00351	CbGpPWpGaD
Sevoflurane—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000263	0.00338	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000262	0.00338	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—GABRA3—Graves' disease	0.000262	0.00337	CbGpPWpGaD
Sevoflurane—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000261	0.00336	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000259	0.00333	CbGpPWpGaD
Sevoflurane—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000256	0.0033	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000252	0.00324	CbGpPWpGaD
Sevoflurane—GRIA1—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.000242	0.00312	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000237	0.00305	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00023	0.00296	CbGpPWpGaD
Sevoflurane—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000224	0.00288	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000222	0.00286	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00022	0.00284	CbGpPWpGaD
Sevoflurane—CYP2E1—thyroid gland—Graves' disease	0.000219	0.0118	CbGeAlD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000216	0.00279	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000215	0.00277	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000212	0.00273	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000201	0.00259	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000198	0.00255	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000189	0.00244	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000181	0.00234	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000176	0.00227	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—GABRA3—Graves' disease	0.00017	0.00219	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000169	0.00218	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000166	0.00214	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000145	0.00187	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000141	0.00181	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GC—Graves' disease	0.000123	0.00159	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GC—Graves' disease	0.000123	0.00159	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000116	0.00149	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000114	0.00147	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000108	0.00139	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000107	0.00137	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.75e-05	0.00126	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.47e-05	0.00122	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—B3GNT2—Graves' disease	9.35e-05	0.0012	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—B3GNT2—Graves' disease	9.35e-05	0.0012	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	9.35e-05	0.0012	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.14e-05	0.00118	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.08e-05	0.00117	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.92e-05	0.00115	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.79e-05	0.001	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—ICAM1—Graves' disease	7.6e-05	0.00098	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	7.11e-05	0.000916	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	6.34e-05	0.000817	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	6.04e-05	0.000778	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IFNG—Graves' disease	5.79e-05	0.000745	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL1B—Graves' disease	5.16e-05	0.000665	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	5.05e-05	0.00065	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	4.6e-05	0.000593	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	4.6e-05	0.000592	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	4.53e-05	0.000584	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	4.46e-05	0.000575	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	4.1e-05	0.000528	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TNF—Graves' disease	3.75e-05	0.000482	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	3.34e-05	0.00043	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GC—Graves' disease	3.31e-05	0.000426	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	3.29e-05	0.000424	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—TNF—Graves' disease	2.98e-05	0.000383	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GC—Graves' disease	2.67e-05	0.000344	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GC—Graves' disease	2.61e-05	0.000337	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—B3GNT2—Graves' disease	2.51e-05	0.000323	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GC—Graves' disease	2.25e-05	0.00029	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—B3GNT2—Graves' disease	2.02e-05	0.000261	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—B3GNT2—Graves' disease	1.98e-05	0.000255	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2RA—Graves' disease	1.72e-05	0.000221	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—B3GNT2—Graves' disease	1.7e-05	0.000219	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GC—Graves' disease	1.21e-05	0.000156	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—B3GNT2—Graves' disease	9.19e-06	0.000118	CbGpPWpGaD
